ArticleOncoTargets and therapy2020

HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice.

Hara Afaloniati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.